Trikafta: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

17 March 2025

  • curprev 15:3015:30, 17 March 2025 Omid Afkhami-Ardakani talk contribs 7,857 bytes +7,857 Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Elexacaftor, Tezacaftor, and Ivacaftor |aOrAn=a |drugClass=Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator |indicationType=treatment |indication=cystic fibrosis (CF) in patients aged 2 years and older who have at least one F508del mutation in the CFTR gene or a mutation in the CFTR gene that is responsive based on clinical and/or in vitro data. If the patient's genotype is unkn..."
Retrieved from "https://www.wikidoc.org/index.php/Trikafta"